Triasima Portfolio Management Inc. Catalent, Inc. Transaction History

Triasima Portfolio Management Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Jul 20, 2022	SELL	$94.19 - $124.49 $2.33 Million - $3.08 Million	-24,735 Closed	0 $0
Q3 2021 Mar 10, 2023	BUY	$109.17 - $142.35 $2.7 Million - $3.52 Million	24,735 New	24,735 $3.29 Million
Q3 2021 Jul 20, 2022	BUY	$109.17 - $142.35 $2.7 Million - $3.52 Million	24,735 New	24,735 $3.29 Million

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $10.9B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Triasima Portfolio Management Inc., based on Form 13F filings with the SEC.

Stay updated on Triasima Portfolio Management Inc. with notifications on news.